- €89.79m
- €75.87m
- €129.10m
R2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 93.5 | 92.8 | 104 | 128 | 129 |
Cost of Revenue | |||||
Gross Profit | 49.9 | 51.1 | 56.5 | 67.6 | 67.3 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 91.6 | 89.5 | 100 | 119 | 125 |
Operating Profit | 1.93 | 3.32 | 3.38 | 8.79 | 3.63 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1.54 | 1.97 | 3.58 | 10 | 3.36 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.58 | 3.17 | 5.17 | 12 | 3.63 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1.58 | 3.17 | 5.17 | 12 | 3.63 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.58 | 3.17 | 5.17 | 12 | 3.63 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.139 | 0.137 | 0.2 | 0.474 | 0.146 |
Dividends per Share |